DAPK1 and neoplasm: A close association between BRAF mutation and aberrant methylation of several tumor-suppressor genes in PTC, including the genes for tissue inhibitor of matrix metalloproteinase-3 (TIMP3), death-associated protein kinase (DAPK), and retinoic acid receptor β2 (RARβ2) has been reported [38].